and (D) heterozygous mutant colon, viewed from the luminal side. (C) Southern blot analysis on genomic DNA from littermates of a Smad3 heterozygote (ϩ/-) mating. Tail DNA, obtained from 3-weekold pups, was digested with EcoRI and probed with the 3Ј probe (Probe B); wild-type, 6.5 kb; mutant, 5.0 kb. Wild-type, (ϩ/ϩ); heteroof the G418-FIAU resistant ES colonies exhibited a muzygote, (ϩ/-); homozygous mutant, (Ϫ/Ϫ) tant (14 kb) Smad3 band upon Southern blot analysis ( Figure 1B) . A 3Ј external probe verified these results (Graff et al., 1996) . These fragments were then used to (not shown). Four of the recombinant ES cell colonies screen a murine 129/Sv genomic phage library, and a were injected into C57BL/6 blastocysts, each of which 15 kb genomic clone was isolated. Sequence analysis transmitted the mutant allele into the germline (Figidentified a 191 bp stretch that, when translated, exhibure 1C) . ited absolute amino acid conservation with the second exon of the rat and human Smad3 genes (data not
Smad3 Is Expressed Embryonically shown). and in Colonic Epithelium

A targeting vector was constructed and designed to
The presence of the "knocked-in" LacZ reporter gene disrupt the second exon of the Smad3 locus ( Figure 1A ).
within the Smad3 coding sequence ( Figure 1A ) permitIn addition, a LacZ gene was introduced into exon 2 of ted ␤-galactosidase staining to analyze endogenous the Smad3 gene, together with an internal ribosomal expression of Smad3 in embryos and adults. Smad3 is entry site (IRES), to permit translation of the ␤-galactosiexpressed in many developing tissues with highest levdase reporter from the interrupted Smad3 transcript els in mesenchymal derivatives ( Figure 2B ). Of note, ( Figure 1A ). This strategy was designed to create a null Smad3 is expressed in the adult colon, with highest allele for several reasons. First, the IRES-LacZ-Neo inlevels in the muscularis propria and the submucosa and sertion into the second exon should truncate the gene lower levels in the epithelium ( Figure 2D ). Thus, Smad3 such that the carboxyl-terminal active domain of Smad3 is a widely expressed TGF␤ signaling intermediate. would not be produced Heldin et al., 1997) . Second, the IRES-LacZ-
The Recombinant Smad3 Allele Behaves Neo cassette is inserted at the region where point mutaas a Recessive Allele tions create loss-of-function Smad proteins (Eppert et The germline chimeras were bred with 129/Sv females al., 1996; Schutte et al., 1996) . Finally, sequence analysis to generate an inbred 129/Sv Smad3 Ϫ/ϩ mouse strain indicated that alternative splicing around exon 2 would and also to C57BL/6 females to generate F 1 hybrid shift the open reading frame (see below).
(129/Sv ϫ C57BL/6) heterozygotes. Heterozygous mice Two hundred eighty-eight G418-FIAU resistant ES cell (Smad3
) from both backgrounds were viable and ferclones were isolated and screened for diagnostic Southtile ( Figures 1C and 4) . The heterozygotes have been ern blot patterns with a 5Ј probe external to the recombination cassette ( Figures 1A and 1B) . Forty-three (15%) observed for up to nine months with no apparent signs of altered phenotype compared to wild-type littermates (not shown). Thus, in two different genetic backgrounds, the mutant allele behaves as a recessive trait that is only phenotypically manifest in the homozygous condition (see below).
To characterize the nature of the mutation, we examined expression from the mutant allele using RT-PCR with a battery of primers that span the Smad3 open reading frame ( Figures 3A and 3B ). Figure 3B shows the location of the primers with respect to the exon 2-LacZ insertion (shaded). RT-PCR analysis of RNA extracted from E14.5 wild-type, heterozygous, and homozygous mutant littermates showed evidence for only one transcript generated from exon 1 that spliced around the targeted exon ( Figure 3A ). This aberrant transcript included exon 1 (P1/3), excluded exons 2 and 3 (P9/10; P6/7b), and included the remaining exons (P7a/8; and P1/8 lower 1 kb band). The resultant aberrantly spliced mutant transcript migrated as a slightly smaller band, due to the loss of exons 2 and 3, compared to the wildtype band on Northern blots (not shown) using a fulllength probe. We did not detect evidence for any additional Smad3 transcripts from the mutant locus.
We cloned the mutant Smad3 transcript to examine its molecular and functional properties. Sequence analysis revealed aberrant splicing from exon 1 to exon 4 resulting in an altered reading frame that terminated nine amino acids downstream of the exon 1 to 4 splicing event. Thus, in the unlikely event that a truncated peptide is translated from the aberrant transcript, the 68 amino acids of exon 1 would be present together with nine additional missense amino acids. activity or perturbed the functions of other Smad family 2 and 3, produced from the mutant allele. Oligonucleotide primers, illustrated in (B), were used for PCR to assess the transcripts proproteins, we tested its function in Xenopus laevis, a duced in a wild-type (ϩ/ϩ), a heterozygote (ϩ/-), and a homozygous model system for the study of TGF␤ and Smad signaling mutant (Ϫ/Ϫ). A Smad3 cDNA plasmid was a positive control (Ctr). (Graff et al., 1996; Graff, 1997) . We microinjected mRNA ␤-actin served as loading control.
that encoded the Smad3 mutant peptide into 1-cell Xe-(B) RT-PCR strategy and sequence of the mutant transcript.
nopus embryos. The microinjected embryos had no phePositions of the primers, exons 1, 2, and 3 (E1, E2, E3) and the notypic differences compared to wild-type sibling emtargeted deleted portion of exon 2 (shaded) are illustrated. The mutant transcript was cloned by RT-PCR with primers 1 and 8. bryos ( Figure 3C ). To further characterize the function Sequence analysis indicated splicing (downward arrow) from the of the mutant peptide, we utilized the animal cap assay.
first to the fourth exon that resulted in premature termination.
Animal caps are fated to become ciliated epidermis or (C) Expression of mutant Smad3 peptide had no effect on Xenopus skin; however, their fate can be changed to mesoderm embryos. mRNA encoding the mutant Smad3 peptide (Smad3 Mut, by activating Smads or to neural tissue by inhibiting 2 ng) was injected into the animal pole of 1-cell stage embryos. The TGF␤ signaling Graff et al., embryos were allowed to develop to a tadpole stage and photographed. Embryos injected with the mutant peptide were identical 1996; Graff, 1997; Suzuki et al., 1997) . When the mutant to sibling control embryos.
peptide was expressed in the animal cap, neither meso-(D) The mutant Smad3 peptide had neither positive nor inhibitory dermal (muscle actin and globin) nor neural (NCAM) function. Synthetic mRNAs were injected into the animal pole of markers were induced ( Figure 3D ). Together, these re-1-cell stage embryos, and animal caps were explanted at the blassults indicate that the mutant peptide had neither positula stage and cultured until stage 27. Total RNA was harvested tive nor negative activity. To directly determine if the and analyzed by RT-PCR. The mutant Smad3 peptide (S3 mut, 2ng) mutant peptide had dominant negative activity, we coindid not induce mesodermal (M. actin, globin) or neural (NCAM) markers. Coinjection of Smad2 (2 ng) or Smad5 (2 ng) with mutant Smad3 jected the mutant Smad3 with Smad2 or Smad5. In the (2 ng) did not block Smad2 or Smad5 activity. ubiquitously animal cap assay, coinjection is a method to determine expressed, was a loading control (Krieg et al., 1989) . RNA from whether the mutant Smad3 inhibits either the wild-type embryos was a positive control; ϪRT is identical to the embryo lane injected Smad or endogenous Smad4 (Candia et al., except reverse transcriptase was omitted; control animal caps did 1997). We found that Smad2 induced the expression of not express mesodermal or neural markers. muscle actin, and this expression was not altered by coinjection of the mutant Smad3 ( Figure 3D ). Similarly, Xenopus assays, the Smad3 mutant peptide had no the presence of the mutant Smad3 had no effect on the activity when injected alone and did not appear to interSmad5 induction of globin ( Figure 3D ). Equivalent data were obtained with Smad1 (not shown). Therefore, in fere with Smad1, Smad2, Smad4, nor Smad5 function. These data are consistent with the mouse recessive mice. In both genetic backgrounds, however, the homozygous mutant mice had significantly shortened life spans phenotype and support the notion that the targeted Smad3 mutation is a null.
compared to wild-type or heterozygous littermates (Figures 4C and 4D) . The decrease in life span was more pronounced in the inbred background, consistent with Homozygous Smad3 Ϫ/Ϫ Mice Are Viable Homozygous mutant Smad3 mice were generated from the presence of modifier loci. both the inbred and hybrid Smad3 mouse strains by intercrossing the appropriate heterozygotes. Southern blot ( Figure 1C ) and PCR-based analysis (not shown) of
Smad3 Mutant Mice Develop Colorectal Tumors
We analyzed a cohort of 10 wild-type, 38 heterozygous, weanlings demonstrated that the homozygous mutant mice were viable. In the hybrid background, genotypic and 12 homozygous inbred 129/Sv mice. As the homozygous mutant mice aged beyond 18 weeks, they exhibited analysis of several litters revealed the following number of progeny: 37 (26%) wild-type, 71 (50%) heterozygotes, signs of distress including fur-ruffling and lethargy (not shown). By 24 weeks, rectal prolapse was observed in and 33 (23%) nulls. In the inbred genetic strain, we found 27 (24%) wild-type, 58 (52%) heterozygous, and 75% (9/12) of Smad3 mutants ( Figures 5A and 5B). These mutant mice also had distended abdomens and internal 26 (24%) null progeny. This is consistent with the expected Mendelian ratios in both backgrounds. Thus, the examination revealed dilated large and small bowels suggestive of colonic obstructions ( Figure 5C ). Smad3 Ϫ/Ϫ mutants proceeded normally through embryonic development.
Between 18 and 24 weeks, 100% (12/12) of inbred Smad3 Ϫ/Ϫ mutants demonstrated signs of distress, and One hundred percent of the Smad3 Ϫ/Ϫ homozygotes did exhibit several overt phenotypes when compared all had evidence of tumor formation. Ten of the Smad3 mutant mice were studied in detail. Inspection of other to their heterozygote or wild-type littermates (Figure 4) . In both the hybrid (129/Sv ϫ C57BL/6) and inbred (129/ organs and tissues revealed no apparent differences from wild-type or Smad3 heterozygous littermates. One Sv) backgrounds, null mutants are approximately 20%-30% smaller than heterozygous or wild-type littermates exception is that lymph nodes in several mutant animals were enlarged. To examine the large bowels of the mu-( Figures 4A and 4B ), and the males exhibit a more pronounced size reduction than do the females (not shown).
tant mice in greater detail, we removed the gastrointestinal tracts en bloc. In all specimens examined, multiple A second characteristic phenotype of the mutant pups is a peculiar rounded posture suggestive of possible lesions were observed, exclusively in the large intestine ( Figures 5D and 5E , Table 1 ). Figure 5 shows typical skeletal abnormalities ( Figure 4A , not shown). Analysis of several mutant skeletons confirmed the proportional examples of the gross morphology of the intestines. In some specimens, large masses were observed in the size reduction in the mutants, but no obvious defects were detected to account for the altered posture of the proximal region of the colon ( Figure 5D , Table 1 ). In others, large masses were present in the distal end of homozygotes (not shown).
The adult Smad3 homozygous mutant mice were ferthe bowel ( Figure 5E , Table 1 ). Smaller lesions were detected in the intervening colon ( Figures 5D and 5E , tile and produced homozygous litters, albeit at reduced efficacy compared to wild-type or Smad3 heterozygous Table 1 ). Some of the tumors obstructed the lumen of the neoplastic glands were more irregular than those observed in the previous tumor (compare Figure 6F to 6B or 6C). The neoplastic glands had ruptured and released mucin into the supporting stroma ( Figure 6F ), and we also detected a marked desmoplastic reaction ( Figure  6F ). These are characteristics observed in human colorectal cancers (Fenoglio-Preiser et al., 1989; Bresalier and Kim, 1998) . Consistent with the more atypical nature of this neoplasm was the deeper penetration of the neoplastic cells into the muscle layer where they formed distinct glands ( Figure 6E ). The Smad3 mutant mice also contained highly aggressive tumors ( Figures 6G-6I ). These aggressive tumors invaded freely through all layers of the bowel forming large mucin-filled glands and mucous lakes on the surface of the intestine ( Figure 6G ). In addition, the neoplastic cells formed branched glands and nests of back-to-back glands ( Figures 6H and 6I) . Again, the neoplastic glands were surrounded and separated by an expanded desmoplastic stroma ( Figure 6H ). Table 1 summarizes the colorectal neoplasms analyzed in ten 129/Sv inbred Smad3 homozygous mutant mice. Careful examination of the small intestines in the ( Table 1) . We detected early stage hyperproliferative or ( Table 1 ). In addition, approximately one-third of the tumors invaded through all layers of the bowel wall (Tathe intestine as illustrated by the dilation of the bowel ble 1). The distribution of the cancers was asymmetric proximal to the masses ( Figures 5D and 5E) .
with a preponderance of the tumors located at the ends of the bowel (Table 1 ). The average size of the tumors Smad3 Mutant Mice Develop a Spectrum was approximately 0.7 cm with the larger lesions present of Adenocarcinomas at either end of the lower intestine and the smaller To determine the nature of the colorectal masses, we masses located in the intervening colon (Table 1) . The examined the tumors histologically. Examination of the finding of a wide range of tumors within a single mouse, sections revealed a wide range of tumor size from 0.1 including lesions that appear to be polyps, suggests to 2.5 cm (Table 1) . By microscopic analysis, a spectrum that individual animals exhibit multiple stages of the of tumors that ranged from hyperplastic lesions and natural history of tumorigenesis. adenomatous polyps (not shown) to cancerous lesions with progressive degrees of atypia was observed, and Smad3 Ϫ/Ϫ Tumors Contain APC extent of invasion was documented ( Figure 6 , Table 1 ).
and Are Hyperproliferative Figures 6A-6C illustrate a lesion with a limited depth
The APC gene has been implicated in human colon of neoplastic invasion. The neoplastic colonic epithelium cancer, and mice with mutations in this gene exhibit formed a plaque-like mass that is distinct from the adjapolypoid lesions albeit primarily in the small, rather than cent normal mucosa ( Figure 6A ). Focally, in the base of large, intestine (Su et al., 1992) . To determine whether the crypts, there is evidence of increased mitotic figures loss of APC occurred in the Smad3 neoplastic process, coupled with loss of the normal cellular polarity. In addiwe examined APC expression by immunohistochemistry tion, the glands are abnormally branched and dilated with carboxy-and amino-terminal APC antibodies. Adja- (Figures 6B and 6C ). This tumor extended into and cent to the tumors, both antibodies detected APC stainthrough the submucosa and the neoplastic glands abuting confined to the apical and lateral region ( Figure 7A ). ting the muscle wall ( Figure 6B ). In a typical example of In contrast, APC expression is widespread throughout a more aggressive tumor ( Figures 6D-6F) , the glandular the cancers ( Figure 7B ). Thus, loss of APC does not atypia was more dramatic than that noted above and appear to be a contributing factor to the emergence of neoplasia in Smad3 mutant mice. resulted in numerous mucin-filled cysts. Furthermore, To determine the role of increased proliferation in the had spread to distant sites, we analyzed the mesenteric lymphatics and the enlarged lymph nodes histologically. Smad3 neoplastic process, we assessed expression of proliferating cell nuclear antigen (PCNA), a marker of Some of the lymphatics were filled with mucin that we interpret as being produced by adenocarcinoma (Figure cell division. In the colonic tissue adjacent to a colon cancer, PCNA staining was confined to the base of the 8A). We also found mucin-filled structures at distant sites including enlarged thoracic lymph nodes ( Figure  crypts (Figure 7C ). In contrast, enhanced staining, and hence proliferation, was widespread throughout the tu-8B). The architecture of these nodes was distorted by the replacement of the normal lymph tissue with mucin mor tissue ( Figure 7D ). Therefore, hyperproliferation appears to be a component of the carcinogenic process produced by adenocarcinoma ( Figure 8B ). Figures 8C and 8D demonstrate definitive distant spread of the adeobserved in the Smad3 mutant mice.
nocarcinoma into a lymph node where a metastatic, well differentiated neoplastic gland was present within the
Adenocarcinoma Is Present in Lymph Nodes
In humans with colorectal adenocarcinomas, metastatic afferent lymphatic of the node. Thus, mutation of Smad3 function in mice results in malignant, metastatic transspread typically initiates in the lymphatics and then progresses to involve regional lymph nodes (Fenoglioformation of colonic epithelium. Preiser et al., 1989; Cohen et al., 1997; Bresalier and Kim, 1998) . We observed macroscopic evidence of enlarged Hybrid (129/Sv ϫ C57BL/6) Smad3 Ϫ/Ϫ Mutants Have Colorectal Cancer lymph nodes in a number of mutant mice (not shown). This enlargement is consistent with either reactive
We also analyzed the Smad3 mutation on a 129/Sv ϫ C57BL/6 hybrid genetic background. The heterozygous lymphadenopathy or infiltration by carcinoma. To determine if the adenocarcinomas in the Smad3 mutant mice animals have been observed for up to nine months with no apparent abnormalities. Thirty-eight hybrid homozythe adenocarcinoma is much lower in the hybrid background, and to date only approximately 30% of the hygotes have reached five to eight months of age. Eleven (30%) of the hybrid homozygotes exhibited distress; brid mice have developed colorectal cancers. These data provide evidence for the potential importance of although, this occurred over a much broader period of time than seen in the inbred mice. Similar to what was strain-specific genetic modifying factors in the genesis of colorectal adenocarcinomas in a Smad3 mutant backobserved in the inbred background, hybrid mutants exhibited distended abdomens, rectal prolapse, and obground. struction of the gastrointestinal tract (not shown). Histopathological analysis demonstrated similar findings to those observed in the 129/Sv background with larger Discussion lesions at the ends of the colon, glandular and cellular atypia, and invasion through the bowel. However, in the Most forms of human cancer result from the mutation of multiple oncogenes within the same cell (Kinzler and hybrid background, there was a greater variability in the time course of disease and the tumors were less White, 1998) . Tumor suppressor genes have been implicated as major participants in maligaggressive and smaller than those present in the inbred background (not shown). In addition, the penetrance of nancy. The availability of animal models through the generation of gene knockouts has revealed many inhumans. In addition, in both mice and humans the cancer is limited to the colorectum. Moreover, as in humans, sights into the role of tumor suppressors in the development of malignancy. For example, p53 mutant mice dethe majority of the tumors are found at the two ends of the lower intestine with fewer tumors in between (Fenogvelop spontaneous tumors, primarily of the lymphoid lineage (Donehower et al., 1992; Jacks et al., 1994a ). lio-Preiser et al., 1989 Cohen et al., 1997; Bresalier and Kim, 1998) . This may hint at a fundamental biological Surprisingly, other tumor suppressors, like RB and NF-1, believed to cause cancer in humans with single hit kinetproperty of colorectal cancer. It is possible that a single mutation in Smad3, albeit at both alleles, recapitulates ics, do not have such clear roles in mouse models (Clarke et al., 1992; Jacks et al., 1992 Jacks et al., , 1994b Lee et al., the sequence observed for the human disease. Ultimately, the Smad3 mutant mice will be evaluated for 1992; Brannan et al., 1994) .
In this report, we identify Smad3 as a potent tumor accumulation of other genetic changes such as in p53 or ras. suppressor for colonic epithelium in mice. Inbred Smad3 homozygous mutants uniformly develop colorectal adeSmad3 is an intracellular transducer of TGF␤ signals. TGF␤ signaling inhibits the growth of many cells includnocarcinoma in a temporally defined manner, and metastasic spread of the cancer was detected during the ing colonic epithelium (Derynck, 1994; Liu et al., 1997) . Loss of TGF␤ signaling has been associated with human same time interval. Vogelstein and colleagues have proposed a model in which a multistep process underlies colorectal cancer (Polyak, 1996) . This includes examples of TGF␤ resistance in cancer-derived cells and loss-ofthe genesis of colorectal cancer . This is thought to occur through an orderly sefunction mutations in the TGF␤ type II receptor, Smad2, and Smad4 (Markowitz et al., 1995; Wang et al., 1995 ; quence from normal to hyperplastic epithelium, to adenomas, and then to formation of carcinoma. Ultimately, Eppert et al., 1996; Thiagalingam et al., 1996) . Taken together, these data support a connection between loss the cancers are altered, and this leads to distant metastatic spread. Although we have yet to systematically of TGF␤ signaling and colorectal carcinogenesis. Mice that harbor genetic inactivations of TGF␤ signalanalyze the time course of carcinogenesis, the Smad3 mutant mice seem to contain many or all of the stages ing cascade components including all three TGF␤ ligands, the TGF␤ receptor, Smad2, or Smad4 do not develop proposed in the human model of colon cancer progression. The multiple stages, invasiveness, metastasis, and cancer (Shull et al., 1992; Kulkarni et al., 1993; Dickson et al., 1995; Kaartinen et al., 1995; Oshima et al., 1996 ; histopathology, are similar in Smad3 mutant mice and Sanford et al., 1997; Sirard et al., 1998; Waldrip et al., null mice might be the result of abrogation of the TGF␤1 signal. 1998; Yang et al., 1998) . This is likely the result of the death of the animals from other causes either in utero or To date, Smad3 mutations have not been detected in human colorectal cancers (Riggins et al., 1997 ; Arai et early in postnatal life. Mice with conditional compound mutations at the APC and Smad4 loci have recently al., 1998). What might account for the discrepancy between mice and humans? One possibility is that the been reported to exacerbate the intestinal polyposis observed in the APC mutant mice. However, unlike the present status of human tumor studies may be insufficiently sensitive to detect a broad spectrum of inactivathuman condition, these tumors were small, did not invade through the muscle layer, were not metastatic, and ing mutations (Riggins et al., 1997) . Of note, loss-ofheterozygosity (LOH) of 15q, the chromosomal location primarily arose in the small intestine (Takaku et al., 1998) .
Colonic epithelial cells proliferate in the bottom of the of Smad3, had been observed in a subset of human tumors including colorectal cancers (Wick et al., 1996) . crypt and migrate toward the lumen as they transit from a proliferative to a differentiated state. The TGF␤ type It is also possible that the function of Smad3 in the mouse is more similar to the function of Smad2 in hu-II receptor and the TGF␤1 ligand are expressed in the luminal half of the crypt where differentiation occurs mans. Such alternate use of related family members in different species has precedent, for example, in the (Oshima et al., 1997) . The phenotype observed in the Smad3 mutant mice indicates that inactivation of the ephrin signaling gene family (Krull et al., 1997; Wang and Anderson, 1997) . Smad2 and Smad3 are over 90% TGF␤ signaling pathway relieves some epithelial cells from the differentiation signal and, instead, the proliferaidentical at the amino acid level, and in biochemical experiments they appear to play analogous roles downtive state is maintained leading to tumor formation. Consistent with this idea, overexpression of Smad3 inhibits stream of the TGF␤ receptor Liu et al., 1997; Nakao et al., 1997a Nakao et al., , 1997b . Our data indicate proliferation of epithelial cells, and blockade of Smad3 function abrogates the growth inhibitory effects of TGF␤ that in murine colonic epithelium, Smad2 cannot compensate for this loss of Smad3 function. These data Liu et al., 1997) . The pattern of expression of TGF␤1 in the colonic epithelium suggests suggest a unique role for Smad3 in regulating the growth of colonic epithelium. that the cancer phenotype we observed in the Smad3 
Experimental Procedures
The primers were used in PCR, and the fragment was subcloned into the BamHI and EcoRI sites of pCS2 and sequenced. The plasmid Targeting Vector (pCS2-mutSmad3) was linearized with NotI and transcribed in vitro Degenerate oligonucleotides based on conserved sequences as described (Graff et al., 1996) . Two independent pCS2-mutSmad3 among Smad proteins were used to amplify an approximately 150 clones were tested with identical results. To make other synthetic bp DNA fragment from mouse E8.5 cDNA as described (Graff et al., mRNAs, the pSP64T-derived plasmids containing Smad2, Smad1, 1996) . A mouse 129/Sv genomic library was screened using this and Smad5 were linearized and transcribed in vitro (Graff et al., 150 bp DNA fragment as a probe. A positive phage containing an 1996; Suzuki et al., 1997) . approximately 15 kb insert was identified. A 2 kb EcoRI-BglII fragXenopus embryos were obtained, microinjected, and cultured, ment was subcloned, and sequenced, and found to contain exon 2 and animal caps were dissected (Graff et al., 1996) . Embryos were of Smad3 ( Figure 1A) . To generate the 3Ј arm of the targeting vector, either uninjected (control) or injected with synthetic mRNA as dea 2.7 kb SstI-SstI fragment, located 3Ј of exon 2, was modified at scribed in the figure legends. All embryonic stages are according both ends with NotI linkers and subcloned into the unique NotI site to Nieuwkoop and Faber (1967) . of the plasmid pGKneoTK3.IRESLacZ, and the resulting clone is To evaluate Xenopus embryonic tissues, RNA was extracted and designated pMad5.8. To generate the 5Ј arm of the targeting vector, analyzed by RT-PCR as described (Graff et al., 1996) . The conditions a 5.2 kb SstI-SstI fragment was modified with SmaI and SalI linkers for the PCR detection of the transcripts for muscle actin, NCAM, and subcloned into the unique PmeI-SalI sites of pMad5.8. The 3Ј EF-1␣, and globin were previously described (Graff et al., 1996) . end of the 5.2 kb fragment is 76 bp from the end of the exon 2 coding sequence. The final construct is shown in Figure 1A .
Tumor Histology Homozygous Smad3 mutant mice were sacrificed when they exhibited distress and subjected to standard necropsy. All major organs Generation of Smad3 Mutant Mice were closely examined under the dissecting microscope, and samSalI-linearized targeting vector (25 g) was electroporated into R1-ples of each organ were processed into paraffin, sectioned, and ES cells that were selected in 250 mg/ml G418 and 0.5 mM FIAU. examined histologically. Tumor specimens from the lower intestines The G418-FIAU-resistant ES colonies were picked and subjected were fixed in 10% formalin overnight, then processed, embedded to Southern analysis (Figure 1 ). Positive ES clones were also subin paraffin, and 6 m sections were stained with hematoxylin and jected to Southern analysis using a 500 bp 3Ј probe (Figure 1) . eosin and photographed. Four positive ES clones were injected into C57BL/6 blastocysts For immunohistochemistry, paraffin sections were deparaffinized, and transferred into pseudopregnant ICR female recipients (Charles rehydrated, and blocked in 1.5% normal goat serum for 30 min at River). The resulting chimeras were bred with C57BL/6 females. room temperature. Sections were incubated with either rabbit antiGermline transmission was screened by coat color and confirmed APC C-terminal antibody (Santa Cruz, 1:200), rabbit anti-APC N-terby the same Southern analysis. To obtain the targeted Smad3 allele minal antibody (Santa Cruz, 1:500), or mouse monoclonal anti-PCNA in an inbred 129/Sv background, a male chimera with 100% germline (proliferating cell nuclear antigen) antibody (Santa Cruz, 1:50) at 4ЊC transmission was directly bred with 129/Sv females.
overnight. The detection of the primary antibodies was done with an immunoperoxidase system (Vectastain ABC kit, Vector). The stained sections were then examined and photographed. Genotype of Smad3 Mutant Mice Heterozygous Smad3 mice were genotyped by Southern analysis Received May 22, 1998; revised August 13, 1998. as described in Figure 1 . The offspring from subsequent breedings were genotyped by a PCR assay. Two primers derived from exon Acknowledgments 2 of Smad3 were used to detect the wild-type Smad3 allele (primers 9 and 10 below). Two primers from the neomycin cassette were
We thank Mark Henkemeyer for comments and Tammy Oliver, Kim designed to detect the Smad3 targeted allele (Neo1, TGCTCTGATG Meyers, John Shelton, and Rashmi Lalan for technical support. We CCGCCGTGTTCC; Neo2, CGATGTTTCGCTTGGTGGTCGA).
thank Terry Yamaguchi, Richard Harland, Andreas Kispert, and Andy McMahon for providing reagents. J. G. acknowledges the support of Doug Melton in the cloning of mouse Smads. This work was LacZ Staining supported by the Excellence in Education Foundation to L. F. P. E11.5 embryos were dissected, fixed for 30 min at room temperature in 4% PFA in PBS, washed twice with PBS, and incubated in Xgal References staining solution. An analogous staining procedure was employed to determine the colonic expression pattern in adult mice, except Arai, T., Akiyama, Y., Okabe, S., Ando, M., Endo, M., and Yuasa, Y. that the staining was performed at room temperature and 20 mM (1998). Genomic structure of human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett. 122, 157-163. Tris (pH 7.3) was added as described (Hogan et al., 1994) .
